                             2014 IL App (2d) 130044
                                  No. 2-13-0044
                           Opinion filed February 5, 2014
______________________________________________________________________________

                                            IN THE

                             APPELLATE COURT OF ILLINOIS

                              SECOND DISTRICT
______________________________________________________________________________

In re DONALD L., Alleged to be a Person) Appeal from the Circuit Court
Subject to Involuntary Treatment       ) of Kane County.
                                       )
                                       ) No. 12-MH-126
                                       )
(The People of the State of Illinois,  ) Honorable
Petitioner-Appellee, v. Donald L.,     ) Kathryn D. Karayannis,
Respondent-Appellant).                 ) Judge, Presiding.
______________________________________________________________________________

       JUSTICE HUDSON delivered the judgment of the court, with opinion.
       Justices Jorgensen and Birkett concurred in the judgment and opinion.

                                           OPINION

¶1     Respondent, Donald L., appeals the trial court’s order authorizing the involuntary

administration of psychotropic medication and testing for up to 90 days under section

2-107.1(a-5)(4) of the Mental Health and Developmental Disabilities Code (Code) (405 ILCS

5/2-107.1(a-5)(4) (West 2012)).   Respondent contends that the trial court failed to comply with

the Code when it allowed his doctors to administer unspecified tests.    He also contends that the

court erred in finding that he lacked capacity to make a reasoned decision about medication.

We agree with respondent’s first contention and reverse on that point.

¶2                                     I. BACKGROUND

¶3      On November 8, 2012, respondent was involuntarily admitted to the Elgin Mental

Health Center after being adjudicated unfit to stand trial for possession of a weapon.    He had
2014 IL App (2d) 130044


previously been involuntarily admitted from February 17, 2011, to April 25, 2011.      After that,

he was living in the community and receiving mental health treatment.

¶4      On November 21, 2012, respondent’s treating psychiatrist, Dr. Mirella Susnjar, sought an

order authorizing the involuntary administration of psychotropic medication, testing, and medical

procedures.   On December 7, 2012, a hearing was held.

¶5      Susnjar testified that respondent was diagnosed with schizophrenia, undifferentiated type,

which is a serious mental illness.    She said that respondent heard voices that he perceived as

real.   Respondent believed that the Mormon Church was a threat to him and that the voices

were warning him about it.       Susnjar said that respondent demonstrated symptoms such as

hallucinations and difficulty socializing with people.      In her opinion, respondent displayed

unreasonable fears and false beliefs, which made him unable to appreciate his problems or make

decisions about medication.     She opined that his mental illness caused a deterioration of his

ability to function, including making him unfit to stand trial.

¶6      Susnjar stated that respondent did not believe that he had a mental illness. She said that

she spoke with him four times to discuss medication and that he said that he would not take it,

expressing strong beliefs that the medications would hurt him, make him fat, possibly cause him

to transfer birth defects to his future partner, and cause side-effects that he previously

experienced with psychotropic medications.

¶7      Susnjar requested to administer risperidone, olanzapine, quetiapine, and aripiprazole for

psychosis and haloperidol and lorazepam for anxiety.         She also requested diphenhydramine

(Benadryl) and benztropine to address side-effects.         She testified specifically about each

medication and stated why she selected it.     Susnjar said that she chose medications that would




                                                -2-
2014 IL App (2d) 130044


be comfortable for respondent to use, but there were also 15 alternate medications she could

offer for respondent to choose from.

¶8     The petition sought to administer the following tests and procedures:

       “Physical exam, weight, vitals: blood pressure, pulse, respiration, temperature, blood

       work: CBC and differential, BUN and creatine, liver function tests, lipid panel, thyroid

       tests, and other tests necessary to evaluate safe administration of medications, level of

       medication in blood, EKG if necessary.”

¶9     Susnjar was asked to outline the tests and procedures she requested, and she stated:

       “Blood pressure, pulse, temperature, blood work in a sense of monitoring the health of

       blood, and it can be CBC and differential, address the function of the kidneys, liver

       function test, TSH, thyroid testing, lipid testing, because as I said sometimes people can

       start to gain weight and we monitor that very carefully.     Any test that is necessary to

       assure a safe administration of medications.      EKG if necessary, as well as level of

       medication in blood.”

There was no further description or explanation of the tests.

¶ 10   Respondent testified about his previous involuntary commitment, during which he was

also diagnosed with schizophrenia, undifferentiated type, and was treated with medications.     He

said that he was initially given only risperidone and that he suffered side-effects.   Respondent

stated that his “face swelled up like a punching bag,” that he “walked around like a zombie,” and

that his speech was slurred. The next day the doctors adjusted the dose and gave him what he

testified was Benadryl, but was actually benztropine, to address the side-effects.     He said that

the side-effects were not alleviated, as his face remained swollen and his speech slurred.      He

said that the side-effects were reported daily.



                                                  -3-
2014 IL App (2d) 130044


¶ 11   Respondent testified that he continued the medications for six months after he was

discharged but saw no changes in his symptoms, while he continued to experience side-effects

such as dizziness, excessive dry mouth, blurred vision, speech impairment, inattentiveness,

disorientation, decreased cognitive performance, swelling of the face and neck, pressure in his

ears, and hearing echoes.        He also gained 45 pounds, although his appetite decreased.

Respondent said that the excess weight affected preexisting hip and sciatic pain.     He needed

hip-replacement surgery and estimated that he needed to lose 15 to 20 pounds to decrease the

pressure on his sciatic nerve.    Respondent met with a psychiatrist who gave him Geodon, but

the side-effects still remained except for the swelling of the face and neck.     He also saw a

general practitioner because of a stomach ulcer and was told that it was caused by the

medications.   Respondent quit taking the medications before his arrest on July 24, 2012.      He

said that the medications never helped his symptoms of schizophrenia and that the side-effects

went away when he stopped taking the medications.

¶ 12   Respondent said that, because of the side-effects he previously experienced, he did not

consent to taking medications.     He said that he would take part in other forms of treatment.

However, he admitted that he attended group therapy only 5 times in 30 days, although Susnjar

told him that he should attend every day.    He did not attend many groups because he believed

that Susnjar knew he could answer questions when asked.

¶ 13   Susnjar was not aware of the numerous side-effects that respondent reported.           No

medical records showed that respondent experienced side-effects other than those after the initial

dose of risperidone.   According to Susnjar, the discharge records showed that, after he was

given benztropine, no debilitating side-effects were reported.   She also noted that the dose of

risperidone had been decreased and that respondent previously told her that his swelling was



                                              -4-
2014 IL App (2d) 130044


reduced after he took Benadryl.    She stated that side-effects are possible, especially with high

doses, but she was not aware of patients gaining weight while having less appetite.        She agreed

that more weight on respondent’s joints would be a problem.           Susnjar stated that she would

suggest different dosages or medications if side-effects occurred.          However, she said that

side-effects can also be associated with other medications.        In her opinion, respondent was

suffering, the benefits of psychotropic medication would outweigh the harm, and respondent did

not have the capacity to make a reasoned decision about medication.

¶ 14   Susnjar stated that respondent was receptive to groups and was able to answer a lot of

fitness questions in them.     However, she believed that group therapy would not change

respondent’s opinion of the world and would not stabilize him unless accompanied by

medication.

¶ 15   The court found that Susnjar provided clear and convincing evidence that there was a

need to administer psychotropic medication against respondent’s will and that the benefits

outweighed the harm.    In regard to the side-effects, the court expressed concern but also noted

that the side-effects were self-reported.    It then found that, although respondent believed that

there were risks, he lacked the capacity to make a decision on the matter.       The court found that

respondent did not understand the advantages and disadvantages of medications and did not

understand how they previously restored him to fitness and how he became unfit again when not

taking them.   The court granted the petition, authorizing the involuntary administration of

psychotropic medications for up to 90 days.     In regard to tests, it quoted the petition in its order,

allowing certain specified tests but also “other tests necessary to evaluate safe administration of

medications.” Respondent appeals.

¶ 16                                        II. ANALYSIS



                                                -5-
2014 IL App (2d) 130044


¶ 17   Relying on the Fifth District case of In re Larry B., 394 Ill. App. 3d 470 (2009), respondent

first contends that the trial court failed to comply with section 2-107.1(a-5)(4)(G) of the Code

(405 ILCS 5/2-107.1(a-5)(4)(G) (West 2012)) when it allowed his doctors to administer

unspecified tests.    Respondent recognizes that the matter is moot because the order for

administration of medication was for 90 days, which time has passed. However, he argues that

exceptions to the mootness doctrine apply. The State agrees that exceptions apply.

¶ 18   “An appeal is considered moot where it presents no actual controversy or where the issues

involved in the trial court no longer exist because intervening events have rendered it impossible

for the reviewing court to grant effectual relief to the complaining party.” In re J.T., 221 Ill. 2d

338, 349-50 (2006). Generally, courts of review do not decide moot questions, render advisory

opinions, or consider issues where the result will not be affected regardless of how those issues are

decided. In re Barbara H., 183 Ill. 2d 482, 491 (1998).

¶ 19   Reviewing courts, however, recognize exceptions to the mootness doctrine: (1) the

public-interest exception, applicable where the case presents a question of public importance that

will likely recur and whose answer will guide public officers in the performance of their duties, (2)

the capable-of-repetition exception, applicable to cases involving events of short duration that are

capable of repetition, yet evading review, and (3) the collateral-consequences exception,

applicable where the order could have consequences for a party in some future proceedings. See

In re Alfred H.H., 233 Ill. 2d 345, 355-62 (2009). There is no per se exception to mootness that

universally applies to mental health cases; however, most appeals in mental health cases will fall

within one of the established exceptions. Id. at 355. Whether a case falls within an established

exception is a case-by-case determination. Id.




                                                -6-
2014 IL App (2d) 130044


¶ 20    “The public interest exception allows a court to consider an otherwise moot case when (1)

the question presented is of a public nature; (2) there is a need for an authoritative determination

for the future guidance of public officers; and (3) there is a likelihood of future recurrence of the

question.” Id. “The ‘public interest’ exception is ‘narrowly construed and requires a clear

showing of each criterion.’ ” Id. at 355-56 (quoting In re Marriage of Peters-Farrell, 216 Ill. 2d

287, 292 (2003). Questions about compliance with the Code involve matters of substantial public

interest. In re Nicholas L., 407 Ill. App. 3d 1061, 1071 (2011).

¶ 21    Here, respondent raises an issue of statutory compliance that is a matter of a public nature.

The only case addressing respondent’s argument is from another appellate district, showing a need

for an authoritative determination of the matter. Further, without an authoritative determination

of the matter from this district, it is likely to recur. Accordingly, the public-interest exception

applies.

¶ 22    The involuntary administration of psychotropic medication to an individual alleged to be

mentally ill implicates substantial liberty interests. In re C.E., 161 Ill. 2d 200, 213-17 (1994).

However, these liberty interests must be balanced against the State’s legitimate interests in

furthering the treatment of mentally ill individuals by forcibly administering psychotropic

medication where an individual lacks the capacity to make reasoned decisions concerning his or

her need for such medication. Id. at 217. In 1991, the General Assembly enacted section

2-107.1 as a mechanism for determining when psychotropic medication may be administered over

an individual’s objections. Id. Section 2-107.1 serves as a guide for balancing the liberty of the

individual and the State’s interest in treating its mentally ill citizens. Id.

¶ 23    Section 2-107.1(a-5)(4) directs that the forced administration of psychotropic medication

is authorized only if the court finds each of the following elements, by clear and convincing proof:



                                                 -7-
2014 IL App (2d) 130044


       “(A) That the recipient has a serious mental illness or developmental disability.

       (B) That because of said mental illness or developmental disability, the recipient currently

   exhibits any one of the following: (i) deterioration of his or her ability to function, as compared

   to the recipient’s ability to function prior to the current onset of symptoms of the mental illness

   or disability for which treatment is presently sought, (ii) suffering, or (iii) threatening behavior.

       (C) That the illness or disability has existed for a period marked by the continuing presence

   of the symptoms set forth in item (B) of this subdivision (4) or the repeated episodic

   occurrence of these symptoms.

       (D) That the benefits of the treatment outweigh the harm.

       (E) That the recipient lacks the capacity to make a reasoned decision about the treatment.

       (F) That other less restrictive services have been explored and found inappropriate.

       (G) If the petition seeks authorization for testing and other procedures, that such testing and

   procedures are essential for the safe and effective administration of the treatment.” 405 ILCS

   5/2-107.1(a-5)(4) (West 2012).

¶ 24   We have not previously addressed a trial court order that broadly allowed “other tests

necessary to evaluate safe administration of medications.” However, In re Larry B. from the

Fifth District provides guidance.

¶ 25   There, a petition was filed seeking the involuntary administration of medication and

testing. The petition stated that the respondent would need periodic blood tests to monitor the

level of drugs in his system and to prevent side-effects. At the hearing, the respondent’s

psychiatrist did not testify about the nature of the tests that he sought to administer. Instead, he

was asked if he wanted the court to allow him to “ ‘do the testing and procedures necessary to

make sure [that the administration of psychotropic medication was] safely and effectively done,’ ”



                                                 -8-
2014 IL App (2d) 130044


and he replied “ ‘Yes.’ ” In re Larry B., 394 Ill. App. 3d at 478. Medication and testing were

ordered, and the respondent appealed. The Fifth District held that there was a lack of compliance

with section 2-107.1(a-5)(4)(G). Noting that the State was required to prove by clear and

convincing evidence that the testing and procedures requested in the petition were “ ‘essential for

the safe and effective administration of the treatment,’ ” the court held that the evidence was

insufficient. Id. (quoting 405 ILCS 5/2-107.1(a-5)(4)(G) (West 2008)). The court found that it

“fell far short of clear and convincing specific expert testimony in support of a request for testing”

and that the trial court’s grant of permission to perform the tests “was made in an informational

limbo, not a fully informed state, warranting the reversal of the trial court’s order.” Id.

¶ 26   Our approach to the sufficiency of the evidence for the administration of medication is also

instructive. In that context, section 2-107.1 establishes strict standards that must be satisfied

before medication may be ordered over the objection of a patient. 405 ILCS 5/2-107.1(a-5)(4)

(West 2012); In re C.E., 161 Ill. 2d at 218. The Code requires specific evidence of the benefits

and risks of each medication so that the trial court can determine whether the State has

demonstrated by clear and convincing evidence that the benefits of the proposed treatment

outweigh the potential harm. In re Suzette D., 388 Ill. App. 3d 978, 985 (2009). “Thus, the State

must produce evidence of the benefits of each drug sought to be administered as well as the

potential side effects of each drug.” Id. The trial court may not “delegate[] its duty of assessing

the risks and benefits of the medication to respondent’s treating physicians.” In re Val Q., 396 Ill.

App. 3d 155, 163 (2009). The same logic applies to the administration of tests. Without specific

evidence, a court is unable to determine which tests are essential to the safe and effective

administration of treatment as required by the Code.            The court may not delegate that




                                                -9-
2014 IL App (2d) 130044


determination to the respondent’s doctors by allowing them to administer unspecified tests as they

see fit.

¶ 27       Here, the court authorized “other tests necessary to evaluate safe administration of

medications” without any evidence of what those tests might be. By doing so, the court allowed

unknown tests to be administered absent clear and convincing evidence that they were “essential

for the safe and effective administration of the treatment.” 405 ILCS 5/2-107.1(a-5)(4)(G) (West

2012). That is, the court delegated its duty to Susnjar, allowing her to administer any test that she

deemed essential. That is contrary to section 2-107.1(a-5)(4)(G). Accordingly, we reverse.

¶ 28       Although our holding with respect to compliance with the Code is dispositive, we

nonetheless address respondent’s next argument, that the trial court’s determination that he lacked

the capacity to make a reasoned decision was against the manifest weight of the evidence. See In

re Nicholas L., 407 Ill. App. 3d at 1074 (noting that resolution of the first issue was dispositive but

nonetheless addressing respondent’s remaining sufficiency-of-the-evidence argument).

¶ 29       Respondent’s argument falls under the exception to the mootness doctrine for matters

capable of repetition yet evading review.         “This exception has two elements.         First, the

challenged action must be of a duration too short to be fully litigated prior to its cessation.

Second, there must be a reasonable expectation that ‘the same complaining party would be

subjected to the same action again.’ ” In re Alfred H.H., 233 Ill. 2d at 358 (quoting In re Barbara

H., 183 Ill. 2d 482, 491 (1998)). “This means that the present action and a potential future action

must have a substantial enough relation that the resolution of the issue in the present case would

have some bearing on a similar issue presented in a future case involving the respondent.” In re

Val Q., 396 Ill. App. 3d at 160 (citing In re Alfred H.H., 233 Ill. 2d at 360).




                                                - 10 -
2014 IL App (2d) 130044


¶ 30   Here, respondent had received similar psychotropic medications in the recent past and is

suffering from a chronic mental illness that can inhibit his ability to make a reasoned decision

about treatment. Thus, it is reasonably likely that he will be subjected to similar involuntary

treatment orders in the future. See In re Suzette D., 388 Ill. App. 3d at 983. “Also, the

challenged action is obviously too short to be fully litigated during the pendency of the order.” Id.

at 983-84. Accordingly, the capable-of-repetition exception is applicable to respondent’s claim.

See id. at 984.

¶ 31   “An individual has the capacity to make treatment decisions for himself when, based upon

conveyed information concerning the risks and benefits of the proposed treatment and reasonable

alternatives to treatment, he makes a rational choice to either accept or refuse the treatment.” In

re Israel, 278 Ill. App. 3d 24, 36 (1996). When determining whether an individual has the

capacity to make a reasoned decision whether to take psychotropic medication, the trial court

should consider the following factors:

       “(1) The person’s knowledge that he has a choice to make;

       (2) The person’s ability to understand the available options, their advantages and

   disadvantages;

       (3) Whether the commitment is voluntary or involuntary;

       (4) Whether the person has previously received the type of medication or treatment at

   issue;

       (5) If the person has received similar treatment in the past, whether he can describe what

   happened as a result and how the effects were beneficial or harmful; and




                                               - 11 -
2014 IL App (2d) 130044


       (6) The absence of any interfering pathologic perceptions or beliefs or interfering

   emotional states which might prevent an understanding of legitimate risks and benefits.” Id.

   at 37.

None of these factors is dispositive, and other factors that are relevant should be considered. Id.

¶ 32   As a reviewing court, we give great deference to the trial court’s factual findings, but will

reverse an order allowing the involuntary administration of psychotropic medication when the trial

court’s findings are against the manifest weight of the evidence. In re Val Q., 396 Ill. App. 3d at

162. A judgment will be considered against the manifest weight of the evidence “only when an

opposite conclusion is apparent or when the findings appear to be unreasonable, arbitrary, or not

based on evidence.” In re John R., 339 Ill. App. 3d 778, 781 (2003).

¶ 33   Here, the trial court’s finding was not against the manifest weight of the evidence.

Although the evidence showed that respondent knew that he had a choice about medication,

Susnjar testified that he was unable to understand the advantages and disadvantages of medication

because his fears and false beliefs made him unable to appreciate his problems. Supporting that

view were the facts that respondent was involuntarily admitted, he did not believe that he had a

mental illness, and he did not attend group treatment as suggested.            Further, although he

previously received several of the medications prescribed, there was a conflict of evidence on how

he tolerated those. Respondent reported numerous side-effects, while Susnjar noted medical

reports that were inconsistent with his testimony and showed that he responded to treatments for

side-effects. The trial court, as the finder of fact, was entitled to credit Susnjar’s testimony based

on medical records over respondent’s testimony.

¶ 34   Based on the evidence as a whole, it was reasonable to conclude that respondent lacked the

ability to understand the risks and benefits of taking medication. Accordingly, the trial court’s



                                                - 12 -
2014 IL App (2d) 130044


finding that respondent lacked the capacity to make a reasoned decision was not against the

manifest weight of the evidence.

¶ 35                                  III. CONCLUSION

¶ 36   The evidence was sufficient to prove that respondent lacked the capacity to make a

reasoned decision about medication. However, the trial court failed to comply with the Code

when it allowed respondent’s doctors to administer unspecified tests.     Accordingly, the

judgment of the circuit court of Kane County is reversed.

¶ 37   Reversed.




                                             - 13 -
